Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NerPharMa DS is the drug substance division of NerPharMa, an Italian Contract Development and Manufacturing Organization (CDMO) and a member of the NMS Group. The company specializes in the chemical development and GMP manufacturing of active pharmaceutical ingredients (APIs), with a particular focus on high-potency compounds (HPAPIs) for oncology. Operating out of a state-of-the-art facility in Nerviano, Italy, NerPharMa DS provides services ranging from route scouting and process optimization to large-scale commercial production. Their capabilities are supported by rigorous quality systems and have been successfully inspected by major regulatory bodies including the FDA and AIFA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NerPharMa DS.